This content is only available for ASCRS Members
ASCRS Membership offers access to 1,000+ educational resources on demand.
Learn More About ASCRS Membership
In recent years, MIGS has become the treatment of choice for early stage of glaucoma. However, problems with current MIGS include anterior chamber hemorrhage, transient elevation of intraocular pressures, and re-adhesion. We examined whether the TRABECTOR®, which is a Trabecular Meshwork Cutter and has already been approved in Japan, could be a new MIGS device that could solve these problems.
